Get the Stockscreener App
12.85
81.24%
5.76
After Hours:
12.29
-0.56
-4.36%
Q 32 Bio Inc stock is traded at $12.85, with a volume of 21.09M.
It is up +81.24% in the last 24 hours and up +134.92% over the past month.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).
See More
Previous Close:
$7.09
Open:
$9.17
24h Volume:
21.09M
Relative Volume:
33.93
Market Cap:
$217.89M
Revenue:
$53.74M
Net Income/Loss:
$33.24M
P/E Ratio:
4.825
EPS:
2.6632
Net Cash Flow:
$-27.40M
1W Performance:
+126.63%
1M Performance:
+134.92%
6M Performance:
+523.79%
1Y Performance:
+664.88%
1-Day Range:
$9.15
$13.15
1-Week Range:
$5.375
$13.15
52-Week Range:
$1.345
$13.15
Q 32 Bio Inc Stock (QTTB) Company Profile
Name
Q 32 Bio Inc
Sector
Industry
Phone
781-999-0232
Address
830 WINTER STREET, WALTHAM
Compare QTTB vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
12.85 | 120.22M | 53.74M | 33.24M | -27.40M | 2.6632 |
VRTX
Vertex Pharmaceuticals Inc
|
437.22 | 110.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
627.74 | 66.53B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
820.63 | 50.27B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.63 | 39.45B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
153.00 | 32.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-25-26 | Initiated | H.C. Wainwright | Buy |
| Feb-11-25 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Feb-11-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-11-24 | Downgrade | Guggenheim | Buy → Neutral |
| Dec-11-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-11-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-06-24 | Initiated | BMO Capital Markets | Outperform |
| Oct-24-24 | Initiated | Raymond James | Strong Buy |
| Sep-11-24 | Initiated | Wells Fargo | Overweight |
| Jun-17-24 | Initiated | Guggenheim | Buy |
| May-21-24 | Initiated | Leerink Partners | Outperform |
| Apr-11-24 | Initiated | Oppenheimer | Outperform |
| Apr-02-24 | Initiated | Piper Sandler | Overweight |
| Jul-28-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-22-22 | Reiterated | BTIG Research | Neutral |
| Feb-22-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-22-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Mar-02-21 | Initiated | Stifel | Hold |
| Dec-14-20 | Resumed | H.C. Wainwright | Buy |
| Aug-11-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-25-20 | Resumed | BofA/Merrill | Buy |
| May-13-20 | Initiated | RBC Capital Mkts | Outperform |
| Mar-16-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Feb-24-20 | Initiated | Chardan Capital Markets | Buy |
| Nov-01-19 | Initiated | Oppenheimer | Perform |
| Sep-10-19 | Initiated | Robert W. Baird | Outperform |
| Apr-12-19 | Initiated | Evercore ISI | Outperform |
View All
Q 32 Bio Inc Stock (QTTB) Latest News
Q32 Bio Inc. (QTTB) Stock: Surges After $55 Million Private Placement Led by Top Biotech Investors - parameter.io
Q32 Bio Secures $55 Million Private Placement to Advance Alopecia Areata Pipeline (QTTB) - Yahoo Finance
Q32 Bio Inc. announced that it expects to receive $53.8 million in funding from Atlas Venture Advisors, Inc., OrbiMed Advisors LLC, BVF Partners L.P., RA Capital Management, L.P. - marketscreener.com
Q32 Bio announces $55M private placement - MSN
Q32 Bio Inc. (QTTB) Secures $55M in Private Placement of Common Stock - GuruFocus
Q32 Bio announces $55 million private placement financing - marketscreener.com
Q32 Bio Announces $55 Million Private Placement Financing - PR Newswire
This Q32 Bio analyst begins coverage on a bullish note; here are top 3 initiations for Friday - MSN
This Q32 Bio Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday - Benzinga
Mizuho initiates Q32 Bio stock coverage with Outperform rating - Investing.com UK
QTTB | Q32 Bio Inc. Common Analyst Forecasts - Quiver Quantitative
Mizuho initiates Q32 Bio stock coverage with Outperform rating By Investing.com - Investing.com Australia
Q32 BIO INC. (QTTB) - MSN
Q32 Bio gears up to report Q1 earnings: What's in the cards? - MSN
Point72 reports 958,768-share (5.7%) stake in Q32 Bio (QTTB) - Stock Titan
Sirenia and Alex Silverstein report 9.9% stake in Q32 Bio (QTTB) - Stock Titan
Q32 Bio (QTTB) Stock Price, News & Analysis - MarketBeat
Number of shareholders of Q32 Bio Inc. – NASDAQ:QTTB - TradingView
Number of shareholders of Q32 Bio Inc. – BOATS:QTTB - TradingView
The organic vs inorganic growth story at Q32 Bio (QTTB) | Q4 2025: EPS Beats ForecastsReal-time Trade Ideas - newser.com
QTTB SEC FilingsQ32 BIO INC 10-K, 10-Q, 8-K Forms - Stock Titan
QTTB Q32 Bio posts massive EPS beat, yet shares dip despite blowout quarter.Working Capital - newser.com
Wall Street Analysts Believe Q32 Bio (QTTB) Could Rally 163.42%: Here's is How to Trade - Yahoo Finance Singapore
How Q32 Bio (QTTB) guidance shapes future expectations | Q4 2025: Profit SurprisesBest Pick - newser.com
Why Q32 Bio (QTTB) might be the portfolio Builder you need (+6.42%) 2026-05-06Fundamentals - newser.com
OrbiMed updates Q32 Bio (QTTB) ownership at 13.3% of common stock - Stock Titan
Opaleye/James Silverman hold 8.59% of Q32 Bio (NASDAQ: QTTB) - Stock Titan
Q32 Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Q32 Bio: Q1 Earnings Snapshot - theheraldreview.com
Regulatory Compliance Risks: Q32 Bio Warns of Internal Control Challenges Under Sarbanes-Oxley and Potential Impact on Investors - TipRanks
Q32 Bio Inc. posts first quarter 2026 financial results and issues corporate update - Traders Union
Q32 Bio Inc. 1Q 2026: Net loss $(7.61M), EPS $(0.54) — 10-Q Summary - TradingView
Q32 Bio Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Q32 Bio (QTTB) narrows Q1 2026 loss and funds runway into 1H 2028 - Stock Titan
Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update - PR Newswire
Wells Fargo initiated coverage on Q32 Bio with a new price target - Quantisnow
Q32 Bio Inc expected to post a loss of 68 cents a shareEarnings Preview - TradingView
Q32 Bio Gears Up to Report Q1 Earnings: What's in the Cards? - sharewise.com
Q32 Bio (QTTB) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Q32 Bio (NASDAQ:QTTB) Trading Down 3.8%What's Next? - MarketBeat
QTTB (Q32 Bio) posts massive Q4 2025 EPS beat, but shares drop 3.85 percent amid investor uncertainty.Market Buzz Alerts - newser.com
Q32 Bio Expands ATM Offering With New $75M Prospectus - The Globe and Mail
QTTB Price Today: Q32 Bio Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Q32 Bio files prospectus for up to $75 million at-the-market share offering - Investing.com UK
Q32 Bio Inc files additional prospectus to offer up to $75 million of common stock - marketscreener.com
Q32 Bio files $75M prospectus supplement after exhausting $14.2M ATM offering - TradingView
Q32 Bio (QTTB) Stock: Momentum Outlook | Q32 Bio Inc. delivers 515.8% EPS surprise topping estimatesRisk Event - Cổng thông tin điện tử tỉnh Lào Cai
Momentum Outlook | Q32 Bio Inc. delivers 515.8% EPS surprise topping estimatesPro Level Trade Signals - Cổng thông tin điện tử tỉnh Lào Cai
Q 32 Bio Inc Stock (QTTB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Q 32 Bio Inc Stock (QTTB) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Morrison Jodie Pope | CEO |
Feb 25 '26 |
Sale |
4.51 |
9,896 |
44,675 |
89,104 |
| Violette Shelia M. | Chief Scientific Officer |
Feb 25 '26 |
Sale |
4.51 |
2,815 |
12,708 |
55,569 |
| Morrison Jodie Pope | CEO |
Dec 02 '25 |
Sale |
3.46 |
22,506 |
77,871 |
99,000 |
| Kalowski Lee | CFO and President |
Dec 02 '25 |
Sale |
3.46 |
9,072 |
31,395 |
39,938 |
0.29%
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):